Abstract:ABSTRACT Staphylococcus aureus is an opportunistic pathogen causing osteomyelitis through hematogenous seeding or contamination of implants and open wounds following orthopedic surgeries. The severity of S. aureus -mediated osteomyelitis is enhanced in obesity-related type 2 diabetes (obesity/T2D) due to chronic inflammation impairing both adaptive and innate immunity. Obesity-induced inflammation is linked to gut dysbiosis, with modification of the gut microbiota by high-fiber diets leading to a reduction in the symptoms and complications of obesity/T2D. However, our understanding of the mechanisms by which modifications of the gut microbiota alter host infection responses is limited. To address this gap, we monitored tibial S. aureus infections in obese/T2D mice treated with the inulin-like fructan fiber, oligofructose. Treatment with oligofructose significantly decreased S. aureus colonization and lowered proinflammatory signaling post-infection in obese/T2D mice, as observed by decreased circulating inflammatory cytokines (TNF-α) and chemokines (IP-10, KC, MIG, MCP-1, and RANTES), indicating partial reduction in inflammation. Oligofructose markedly shifted diversity in the gut microbiota of obese/T2D mice mice, with notable increases in the anti-inflammatory bacterium, Bifidobacterium pseudolongum . Analysis of the cecum and plasma metabolome suggested polyamine production was increased, specifically spermine and spermidine. Oral administration of these polyamines to obese/T2D mice resulted in reduced infection severity similar to oligofructose supplementation, suggesting polyamines can mediate the beneficial effects of fiber on osteomyelitis severity. These results demonstrate the contribution of gut microbiota metabolites to the control of bacterial infections distal to the gut and polyamines as an adjunct therapeutic for osteomyelitis in obesity/T2D. Importance Individuals with obesity-related type 2 diabetes (obesity/T2D) are at a five times increased risk for invasive Staphylococcus aureus osteomyelitis (bone infection) following orthopedic surgeries. With increasing antibiotic resistance and limited discoveries of novel antibiotics, it is imperative we explore other avenues for therapeutics. In this study, we demonstrated that the dietary fiber oligofructose markedly reduced osteomyelitis severity and hyperinflammation following acute implant-associated osteomyelitis in obese/T2D mice. Reduced infection severity is associated with changes in gut microbiota composition and metabolism as indicated by increased production of natural polyamines in the gut and circulating plasma. This work identifies a novel role for the gut microbiome in mediating control of bacterial infections and polyamines as beneficial metabolites involved in improving the obesity/T2D host response to osteomyelitis. Understanding the impact of polyamines on host immunity and mechanisms behind decreasing susceptibility to severe implant-associated osteomyelitis is crucial to improving treatment strategies for this patient population.

Association of Antibiotic Alterations in Gut Microbiota With Decreased Osseointegration of an Intramedullary Nail in Mice With and Without Osteomyelitis

Microbiome dysbiosis by antibiotics protects cartilage degradation in OAOP mice

Remodeling of the Osteoimmune Microenvironment after Biomaterials Implantation in Murine Tibia: Single-cell Transcriptome Analysis

Gut Microbiome Dysbiosis Alleviates He Progression Of Osteoarthritis In Mice

Gut microbiome dysbiosis alleviates the progression of osteoarthritis in mice

Potential efficacy of gut microbiome dysbiosis on alleviation the progress of osteoarthritis in mice

Indigenous microbiota protects development of medication-related osteonecrosis induced by periapical disease in mice

Effects of Staphylococcal Infection and Aseptic Inflammation on Bone Mass and Biomechanical Properties in a Rabbit Model

Gut Microbiota Modulates Osteoclast Glutathione Synthesis and Mitochondrial Biogenesis in Mice Subjected to Ovariectomy

Impact of altering gut microbiota metabolism on osteomyelitis severity in obesity-related type 2 diabetes

Macrophage-to-osteocyte communication: Impact in a 3D in vitro implant-associated infection model

Periodontitis May Impair the Homeostasis of Systemic Bone Through Regulation of Gut Microbiota in ApoE-/- Mice

mRNA Transcriptome Analysis of Bone in a Mouse Model of Implant-Associated Staphylococcus aureus Osteomyelitis

Association between blood markers and the progression of osseointegration in percutaneous prostheses patients—A pilot study

Microbiome-induced increases and decreases in bone matrix strength can be initiated after skeletal maturity

Butyrate Inhibits Osteoclast Activity In Vitro and Regulates Systemic Inflammation and Bone Healing in a Murine Osteotomy Model Compared to Antibiotic-Treated Mice

Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis

Biodegradable Zn-Cu Alloys Show Antibacterial Activity Against Mrsa Bone Infection by Inhibiting Biofilm Formation and Inflammatory Toxic Side-Effects

Gut Microbiome Dysbiosis Alleviate the Progress of Osteoarthritis in Mice

Causal associations between human gut microbiota and osteomyelitis: a Mendelian randomization study

Osteoimmunomodulation mediating improved osteointegration by OGP-loaded cobalt-metal organic framework on titanium implants with antibacterial property